DZ Bank’s CG Oncology CGON Stock Holding History

DZ Bank’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,776	Closed	-$1.47M	–	1086
2026 Q1	$1.47M	Sell	21,776 -33,375	-61%	-$1.89M	﹤0.01%	670
2025 Q4	$2.29M	Sell	55,151 -8,569	-13%	-$355K	﹤0.01%	611
2025 Q3	$2.57M	Buy	+63,720	New	+$1.85M	﹤0.01%	588

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DZ Bank's CGON Position: Q2 2026 in Review

DZ Bank sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 21,776 shares — an estimated $1.47M sold.

DZ Bank first reported a position in CGON in Q3 2025 and held it in 3 quarters. The position peaked at $2.57M in Q3 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

DZ Bank reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
DZ Bank sold 21,776 CG Oncology shares in Q2 2026, an estimated $1.47M.
DZ Bank first reported a position in CG Oncology in Q3 2025 and held it in 3 quarters.
DZ Bank's CG Oncology position peaked at $2.57M in Q3 2025.
227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.